Quadrant HealthCom, The Doctor's Channel to offer video 'CliffsNotes'

Quadrant HealthCom Inc. (QHI) announced a partnership with The Doctor's Channel to provide select video reviews of articles on two QHI titles: Cutis and The Female Patient.

The video reviews will be located at both of the journals' websites, and on The Doctor's Channel site, allowing docs to quickly review top stories in women's health and dermatology.

In addition to providing a summary and the key points of an article, the short videos will feature interviews with authors and leading authorities, according to a company statement. Initially, video will be available for one article from each of the journals each month, although more articles—and QHI titles—could be added later on, according to Mike Banks, co-founder and VP at The Doctor's Channel.

“We're beginning with these two titles, and hoping to incorporate more, such as the American Journal of Orthopedics or Clinician Reviews,” said Banks.

JoAnn Wahl, SVP and managing director of medical education at QHI, said: “We think this medium will provide an interesting extension of our journal offerings and an opportunity for practicing clinicians to see and hear highlights from our national thought-leading authors.”

The Doctor's Channel will roll out several specialty newsletters in the coming months, some of which will incorporate the QHI video reviews, said Banks. The Doctor's Channel is looking for exclusive sponsors for the video reviews, according to Banks.

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.